Literature DB >> 8557725

Cytotoxicity testing of poly(anhydride-co-imides) for orthopedic applications.

M A Attawia1, K E Uhrich, E Botchwey, M Fan, R Langer, C T Laurencin.   

Abstract

The cytotoxicity of a series of poly(anhydride-co-imides) with osteoblast-like cells (MC3T3-E1) was evaluated. The imide component of the copolymers was based on trimellitylimidoglycine (TMA-gly), and the anhydride component was based on either sebacic acid (SA) or 1,6-bis(carboxyphenoxy)hexane (CPH). Cell adhesion and proliferation on surfaces of the polymer discs were observed by environmental scanning electron microscopy (ESEM). During the first 24 h of attachment, cells showed normal morphology when cultured on the various copolymers of CPH. Concurrently, the effects of polymer breakdown products on osteoblast-like cells were evaluated by studying their proliferation (cell numbers), viability (dye exclusion), and morphology (light microscopy). Cell cultures in the presence of these breakdown products resulted in normal morphologies and reached confluency after 7 days. This initial in vitro evaluation with osteoblast-like cells suggests that the poly(anhydride-co-imides) may be viable carriers for osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557725     DOI: 10.1002/jbm.820291010

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  2 in total

1.  Biocompatibility of polysebacic anhydride microparticles with chondrocytes in engineered cartilage.

Authors:  Sathish Ponnurangam; Grace D O'Connell; Clark T Hung; Ponisseril Somasundaran
Journal:  Colloids Surf B Biointerfaces       Date:  2015-08-28       Impact factor: 5.268

2.  Fatty acids derived from royal jelly are modulators of estrogen receptor functions.

Authors:  Paraskevi Moutsatsou; Zoi Papoutsi; Eva Kassi; Nina Heldring; Chunyan Zhao; Anna Tsiapara; Eleni Melliou; George P Chrousos; Ioanna Chinou; Andrey Karshikoff; Lennart Nilsson; Karin Dahlman-Wright
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.